Sunghwan Moon

Title: Sunghwan Moon: Innovator in Pharmaceutical Compositions

Introduction

Sunghwan Moon is a notable inventor based in Hwaseong, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds that have potential therapeutic applications.

Latest Patents

One of his key patents is titled "Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof." This invention provides a GIP analog derived from GIP (1-29, SEQ ID NO: 1), which exhibits both GLP-1 agonist activity and GIPR stimulation activity. The amino acid sequence of the GIP analog is represented by the formula I: Tyr-A2-A3-Gly-Thr-Phe-A7-Ser-Asp-Tyr-Ser-A12-A13-A14-A15-Lys-A17-A18-A19-A20-A21-A22-A23-A24-Trp-Leu-A27-A28-A29-Y. Additionally, the patent includes a pharmaceutical composition comprising the GIP analog and its various uses.

Career Highlights

Sunghwan Moon is currently associated with Beijing Hanmi Pharmaceutical Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His expertise in the field has led to advancements that could potentially improve patient outcomes.

Collaborations

He has collaborated with notable colleagues, including Tao Ma and Bo Zhang, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.

Conclusion

Sunghwan Moon's work in developing GIP analogs represents a significant advancement in pharmaceutical research. His contributions are poised to impact the treatment of various conditions, showcasing the importance of innovation in healthcare.